VP R&D and Site Manager
Stem Cell Medicine Ltd.
frida@stemcell-medicine.com

Frida Grynspan is the VP R&D and Site Manager of Stem Cell Medicine Ltd. Jerusalem, since 2013. Dr. Grynspan is responsible for the development of the company’s cellular therapeutics pipeline in neurological and ischemic indications and of the site management that includes operations, product development and production of pharmaceutical products.  Dr Grynspan has extensive experience in the areas of cellular therapeutics and protein chemistry. She previously served as VP R&D at Gamida Cell and Pluristem leading their bench to clinic development.  Prior to joining Stem Cell Medicine she served as VP R&D at Collplant, a biotechnology biomedical device Company, developing tissue repair products derived from recombinant human collagen.
Dr. Grynspan holds a PhD in Chemistry from the University of Illinois at Chicago and a post-doctoral degree from Harvard Medical School.